Celldex Therapeutics (CLDX) Goodwill (2010 - 2017)

Celldex Therapeutics' Goodwill history runs 8 years deep, the most recent figure standing at $91.0 million for Q4 2017.

• In Q4 2017, Goodwill changed 0.0% year-over-year to $91.0 million; the TTM figure through Dec 2017 stood at $91.0 million (changed 0.0% YoY), while the FY2017 annual figure was $91.0 million, changed 0.0% from the prior year.
• Goodwill for Q4 2017 stood at $91.0 million, roughly flat from $91.0 million in the prior quarter.
• The five-year high for Goodwill was $91.0 million in Q4 2016, with the low at $9.0 million in Q1 2013.
• The 5-year median for Goodwill is $9.0 million (2013), against an average of $29.5 million.
• The sharpest annual moves came in 2013 and 2016: Goodwill changed 0.0% in 2013, then surged 914.79% in 2016.
• Celldex Therapeutics' Goodwill stood at $9.0 million in 2013, then changed by 0.0% to $9.0 million in 2014, then changed by 0.0% to $9.0 million in 2015, then soared by 914.79% to $91.0 million in 2016, then changed by 0.0% to $91.0 million in 2017.
• Business Quant data shows CLDX's Goodwill at $91.0 million in Q4 2017, $91.0 million in Q3 2017, and $91.0 million in Q2 2017.